Compare USANA Health Sciences, Inc. with Similar Stocks
Dashboard
1
The company has declared negative results for the last 7 consecutive quarters
- INTEREST(HY) At USD 0.67 MM has Grown at 550.49%
- OPERATING CASH FLOW(Y) Lowest at USD 63.01 MM
- NET PROFIT(HY) At USD 19.06 MM has Grown at -29.34%
2
With ROE of 6.57%, it has a attractive valuation with a 1.03 Price to Book Value
3
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
USD 407 Million (Micro Cap)
16.00
NA
0.00%
-0.28
3.32%
0.77
Revenue and Profits:
Net Sales:
236 Million
(Quarterly Results - Jun 2025)
Net Profit:
10 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
1.96%
0%
1.96%
6 Months
-27.89%
0%
-27.89%
1 Year
-33.92%
0%
-33.92%
2 Years
-55.18%
0%
-55.18%
3 Years
-65.34%
0%
-65.34%
4 Years
-77.46%
0%
-77.46%
5 Years
-75.29%
0%
-75.29%
USANA Health Sciences, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-3.19%
EBIT Growth (5y)
-18.74%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
1.73
Tax Ratio
47.24%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
62.93%
ROCE (avg)
70.81%
ROE (avg)
18.61%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
1.03
EV to EBIT
6.81
EV to EBITDA
4.61
EV to Capital Employed
1.05
EV to Sales
0.45
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
15.36%
ROE (Latest)
6.57%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 53 Schemes (26.97%)
Foreign Institutions
Held by 79 Foreign Institutions (5.24%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
235.80
249.50
-5.49%
Operating Profit (PBDIT) excl Other Income
26.30
25.90
1.54%
Interest
0.30
0.40
-25.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
10.40
9.30
11.83%
Operating Profit Margin (Excl OI)
70.90%
62.80%
0.81%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -5.49% vs 16.81% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 11.83% vs 106.67% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
854.50
921.00
-7.22%
Operating Profit (PBDIT) excl Other Income
88.60
113.50
-21.94%
Interest
0.30
0.30
Exceptional Items
0.00
0.00
Consolidate Net Profit
42.10
63.80
-34.01%
Operating Profit Margin (Excl OI)
77.60%
101.10%
-2.35%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -7.22% vs -7.77% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -34.01% vs -7.94% in Dec 2023
About USANA Health Sciences, Inc. 
USANA Health Sciences, Inc.
Pharmaceuticals & Biotechnology
USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia. Its product lines include USANA Nutritionals Essentials, Optimizers, Foods, Sense-beautiful science and All Other. Its USANA Nutritionals Essentials product line includes vitamin and mineral supplements that provide a foundation of total body nutrition for every age group beginning with children of approximately one year. Its Optimizers product line consists of targeted supplements designed to meet individual health and nutritional needs. Its Sense-beautiful science product line includes science-based, personal care products that support skin and hair by providing topical nourishment, moisturization and protection.
Company Coordinates 
Company Details
3838 W Parkway Blvd , SALT LAKE CITY UT : 84120-6336
Registrar Details






